The effect of premature chemotherapy termination in breast cancer on relapse

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022566

Enrollment

1916

Registered

2020-08-03

Start date

2020-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: Retrospective data analysis of the tumor documentation system of the Ortenau-Klinikum Offenburg-Kehl Breast Cancer Center. Overall survival and disease-free survival of breast cancer patients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: primary breast cancer, adjuvant chemotherapy recommended.

Exclusion criteria

Exclusion criteria: primary metastasis.

Design outcomes

Primary

Measure	Time frame
Overall survival and disease-free survival depending on premature termination of recommended chemotherapy for breast cancer.	—

Secondary

Measure	Time frame
Subgroup analysis by age and type of tumor	—

Countries

Germany

Contacts

Public ContactHeidrun Männle

Ortenau-Klinikum Offenburg-Kehl

heidrun.maennle@ortenau-klinikum.de0781/472-3501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026